IL6 and atherosclerosis: It has been proposed that inflammation is the driving force in atherosclerosis [2, 3], and strong evidence supports the central role of proinflammatory cytokines, such as interleukin-1β (IL-1β) and interleukin-6 (IL-6) in these pathologies.